FDA Drug Recalls

Recalls / Class III

Class IIID-0034-2021

Product

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Brand name
Cystaran
Generic name
Cysteamine Hydrochloride
Active ingredient
Cysteamine Hydrochloride
Route
Ophthalmic
NDCs
54482-020, 54482-035
FDA application
NDA200740
Affected lot / code info
Lot #: 370655, Exp. 10/31/2020

Why it was recalled

Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Recalling firm

Firm
Leadiant Biosciences, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
9841 Washingtonian Blvd Ste 500, N/A, Gaithersburg, Maryland 20878-7352

Distribution

Quantity
1380 bottles
Distribution pattern
PA and Italy

Timeline

Recall initiated
2020-09-24
FDA classified
2020-10-15
Posted by FDA
2020-10-21
Terminated
2021-11-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0034-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.